-
1
-
-
84893651437
-
Heart disease and stroke statistics-2014 update: A report from the American Heart Association
-
Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014; 129: e28-e292
-
(2014)
Circulation
, vol.129
, pp. e28-e292
-
-
Go, A.S.1
Mozaffarian, D.2
Roger, V.L.3
-
3
-
-
84893549987
-
2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the eighth joint national committee (jnc 8
-
James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) JAMA 2014; 311: 507-520
-
(2014)
Jama
, vol.311
, pp. 507-520
-
-
James, P.A.1
Oparil, S.2
Carter, B.L.3
-
4
-
-
84855353573
-
Heart disease and stroke statistics-2012 update: A report from the American Heart Association
-
Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012; 125: e2-e220
-
(2012)
Circulation
, vol.125
, pp. e2-e220
-
-
Roger, V.L.1
Go, A.S.2
Lloyd-Jones, D.M.3
-
5
-
-
0347423198
-
Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure
-
Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252
-
(2003)
Hypertension
, vol.42
, pp. 1206-1252
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
-
6
-
-
0034627183
-
Effects of ace inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials blood pressure lowering treatment trialists' collaboration
-
Neal B, MacMahon S, Chapman N, et al. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet 2000; 356: 1955-1964
-
(2000)
Lancet
, vol.356
, pp. 1955-1964
-
-
Neal, B.1
MacMahon, S.2
Chapman, N.3
-
7
-
-
0034635838
-
Risks of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials
-
Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355: 865-872
-
(2000)
Lancet
, vol.355
, pp. 865-872
-
-
Staessen, J.A.1
Gasowski, J.2
Wang, J.G.3
-
8
-
-
84859700263
-
-
Guidance for Industry U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) Available at 20 July 2014, date last accessed
-
Guidance for Industry. Hypertension indication: drug labeling for cardiovascular outcome claims. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) Available at: http://www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/ucm075072.pdf. (20 July 2014, date last accessed) 2011
-
(2011)
Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims
-
-
-
9
-
-
0344373794
-
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (allhat
-
Officers A Coordinators for the ACRGTA Lipid-Lowering Treatment to Prevent Heart Attack Trial
-
Officers A, Coordinators for the ACRGTA, Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 2002; 288: 2981-2997
-
(2002)
Jama
, vol.288
, pp. 2981-2997
-
-
-
10
-
-
57349138291
-
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
-
Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417-2428
-
(2008)
N Engl J Med
, vol.359
, pp. 2417-2428
-
-
Jamerson, K.1
Weber, M.A.2
Bakris, G.L.3
-
11
-
-
77951469747
-
Hypertension epidemiology and economic burden: Refining risk assessment to lower costs
-
Cohen JD. Hypertension epidemiology and economic burden: refining risk assessment to lower costs. Manag Care 2009; 18: 51-58
-
(2009)
Manag Care
, vol.18
, pp. 51-58
-
-
Cohen, J.D.1
-
12
-
-
0014200585
-
Results in patients with diastolic blood pressures averaging 115 through 129 mmhg
-
Effects of treatment on morbidity in hypertension
-
Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA 1967; 202: 1028-1034
-
(1967)
Jama
, vol.202
, pp. 1028-1034
-
-
-
13
-
-
0015227657
-
The chemotherapy of hypertension
-
Freis ED. The chemotherapy of hypertension. JAMA 1971; 218: 1009-1015
-
(1971)
Jama
, vol.218
, pp. 1009-1015
-
-
Freis, E.D.1
-
14
-
-
0015912563
-
Drug therapy: Patient compliance
-
Blackwell B. Drug therapy: patient compliance. N Engl J Med 1973; 289: 249-252
-
(1973)
N Engl J Med
, vol.289
, pp. 249-252
-
-
Blackwell, B.1
-
15
-
-
33646835918
-
Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice
-
Burke TA, Sturkenboom MC, Lu SE, et al. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens 2006; 24: 1193-1200
-
(2006)
J Hypertens
, vol.24
, pp. 1193-1200
-
-
Burke, T.A.1
Sturkenboom, M.C.2
Lu, S.E.3
-
16
-
-
67650651982
-
Improving outcomes in hypertensive patients: Focus on adherence and persistence with antihypertensive therapy
-
Elliott WJ. Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy. J Clin Hypertens (Greenwich) 2009; 11: 376-382
-
(2009)
J Clin Hypertens (Greenwich
, vol.11
, pp. 376-382
-
-
Elliott, W.J.1
-
17
-
-
0039607154
-
Compliance with medical regimens: A panel study
-
Davis MS, Eichhorn RL. Compliance with medical regimens: a panel study. J Health Hum Behav 1963; 4: 240-249
-
(1963)
J Health Hum Behav
, vol.4
, pp. 240-249
-
-
Davis, M.S.1
Eichhorn, R.L.2
-
18
-
-
67649523031
-
Medication adherence: Its importance in cardiovascular outcomes
-
Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009; 119: 3028-3035
-
(2009)
Circulation
, vol.119
, pp. 3028-3035
-
-
Ho, P.M.1
Bryson, C.L.2
Rumsfeld, J.S.3
-
19
-
-
0142017677
-
-
Geneva World Health Organization
-
Adherence to Long Term Therapies: Evidence for Action. Geneva: World Health Organization 2003; https://http://www.who.int/chornic-conditions/en/adherence-report.pdf
-
(2003)
Adherence to Long Term Therapies: Evidence for Action
-
-
-
20
-
-
38549098101
-
Medication compliance and persistence: Terminology and definitions
-
Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health 2008; 11: 44-47
-
(2008)
Value Health
, vol.11
, pp. 44-47
-
-
Cramer, J.A.1
Roy, A.2
Burrell, A.3
-
21
-
-
0034515494
-
Predictors of long-term persistence on statins in a subsidized clinical population
-
Catalan VS, LeLorier J. Predictors of long-term persistence on statins in a subsidized clinical population. Value Health 2000; 3: 417-426
-
(2000)
Value Health
, vol.3
, pp. 417-426
-
-
Catalan, V.S.1
LeLorier, J.2
-
22
-
-
25444477545
-
Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis
-
Cramer JA, Amonkar MM, Hebborn A, et al. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin 2005; 21: 1453-1460
-
(2005)
Curr Med Res Opin
, vol.21
, pp. 1453-1460
-
-
Cramer, J.A.1
Amonkar, M.M.2
Hebborn, A.3
-
24
-
-
38549086933
-
The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke
-
Breekveldt-Postma NS, Penning-van Beest FJ, Siiskonen SJ, et al. The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke. Curr Med Res Opin 2008; 24: 121-127
-
(2008)
Curr Med Res Opin
, vol.24
, pp. 121-127
-
-
Breekveldt-Postma, N.S.1
Penning-Van Beest, F.J.2
Siiskonen, S.J.3
-
25
-
-
79952910927
-
Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients
-
Esposti LD, Saragoni S, Benemei S, et al. Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. Clinicoecon Outcomes Res 2011; 3: 47-54
-
(2011)
Clinicoecon Outcomes Res
, vol.3
, pp. 47-54
-
-
Esposti, L.D.1
Saragoni, S.2
Benemei, S.3
-
26
-
-
60549087524
-
Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention
-
Kettani FZ, Dragomir A, Cote R, et al. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke 2009; 40: 213-220
-
(2009)
Stroke
, vol.40
, pp. 213-220
-
-
Kettani, F.Z.1
Dragomir, A.2
Cote, R.3
-
27
-
-
84883465807
-
Adherence to antihypertensive agents improves risk reduction of end-stage renal disease
-
Roy L, White-Guay B, Dorais M, et al. Adherence to antihypertensive agents improves risk reduction of end-stage renal disease. Kidney Int 2013; 84: 570-577
-
(2013)
Kidney Int
, vol.84
, pp. 570-577
-
-
Roy, L.1
White-Guay, B.2
Dorais, M.3
-
28
-
-
33644548016
-
Long-term compliance with salt restriction in Japanese hypertensive patients
-
Ohta Y, Tsuchihashi T, Onaka U, et al. Long-term compliance with salt restriction in Japanese hypertensive patients. Hypertens Res 2005; 28: 953-957
-
(2005)
Hypertens Res
, vol.28
, pp. 953-957
-
-
Ohta, Y.1
Tsuchihashi, T.2
Onaka, U.3
-
29
-
-
0031267929
-
Enhancement of compliance among patients with hypertension
-
Patton K, Meyers J, Lewis BE. Enhancement of compliance among patients with hypertension. Am J Manag Care 1997; 3: 1693-1698
-
(1997)
Am J Manag Care
, vol.3
, pp. 1693-1698
-
-
Patton, K.1
Meyers, J.2
Lewis, B.E.3
-
30
-
-
65549132913
-
The assessment of adherence of hypertensive individuals to treatment and lifestyle change recommendations
-
Uzun S, Kara B, YokusogluMet al. The assessment of adherence of hypertensive individuals to treatment and lifestyle change recommendations. Anadolu Kardiyol Derg 2009; 9: 102-109
-
(2009)
Anadolu Kardiyol Derg
, vol.9
, pp. 102-109
-
-
Uzun, S.1
Kara, B.2
Yokusoglu, M.3
-
31
-
-
84900302482
-
High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (hp lc-ms/ms) urine analysis
-
Tomaszewski M, White C, Patel P, et al. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis. Heart 2014; 100: 855-861
-
(2014)
Heart
, vol.100
, pp. 855-861
-
-
Tomaszewski, M.1
White, C.2
Patel, P.3
-
32
-
-
78751649486
-
Improving the measurement of self-reported medication nonadherence: Response to authors
-
discussion 258-263
-
Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: response to authors. J Clin Epidemiol 2011; 64: 255-257; discussion 258-263
-
(2011)
J Clin Epidemiol
, vol.64
, pp. 255-257
-
-
Morisky, D.E.1
DiMatteo, M.R.2
-
33
-
-
49349115364
-
Predictive validity of a medication adherence measure in an outpatient setting
-
Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008; 10: 348-354
-
(2008)
J Clin Hypertens (Greenwich
, vol.10
, pp. 348-354
-
-
Morisky, D.E.1
Ang, A.2
Krousel-Wood, M.3
-
34
-
-
0030940351
-
The electronic medication event monitor lessons for pharmacotherapy
-
Urquhart J. The electronic medication event monitor. Lessons for pharmacotherapy. Clin Pharmacokinet 1997; 32: 345-356
-
(1997)
Clin Pharmacokinet
, vol.32
, pp. 345-356
-
-
Urquhart, J.1
-
35
-
-
33846468943
-
A checklist for medication compliance and persistence studies using retrospective databases
-
Peterson AM, Nau DP, Cramer JA, et al. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007; 10: 3-12
-
(2007)
Value Health
, vol.10
, pp. 3-12
-
-
Peterson, A.M.1
Nau, D.P.2
Cramer, J.A.3
-
36
-
-
67650828614
-
Measuring concurrent adherence to multiple related medications
-
Choudhry NK, Shrank WH, Levin RL, et al. Measuring concurrent adherence to multiple related medications. Am J Manag Care 2009; 15: 457-464
-
(2009)
Am J Manag Care
, vol.15
, pp. 457-464
-
-
Choudhry, N.K.1
Shrank, W.H.2
Levin, R.L.3
-
37
-
-
58549094914
-
Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication
-
Martin BC, Wiley-Exley EK, Richards S, et al. Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother 2009; 43: 36-44
-
(2009)
Ann Pharmacother
, vol.43
, pp. 36-44
-
-
Martin, B.C.1
Wiley-Exley, E.K.2
Richards, S.3
-
38
-
-
33750047541
-
Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilization
-
discussion 1410
-
Caetano PA, Lam JM, Morgan SG. Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization. Clin Ther 2006; 28: 1411-1424; discussion 1410
-
(2006)
Clin Ther
, vol.28
, pp. 1411-1424
-
-
Caetano, P.A.1
Lam, J.M.2
Morgan, S.G.3
-
39
-
-
84922391679
-
Association of medical treatment nonadherence with all-cause mortality in newly treated hypertensive US veterans
-
Gosmanova EO, Lu JL, Streja E, et al. Association of medical treatment nonadherence with all-cause mortality in newly treated hypertensive US veterans Hypertension 2014; 64: 951-957
-
(2014)
Hypertension
, vol.64
, pp. 951-957
-
-
Gosmanova, E.O.1
Lu, J.L.2
Streja, E.3
-
40
-
-
33747410924
-
Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations
-
Bramley TJ, Gerbino PP, Nightengale BS, et al. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 2006; 12: 239-245
-
(2006)
J Manag Care Pharm
, vol.12
, pp. 239-245
-
-
Bramley, T.J.1
Gerbino, P.P.2
Nightengale, B.S.3
-
42
-
-
0025338414
-
On white-coat effects and the electronic monitoring of compliance
-
Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990; 150: 1377-1378
-
(1990)
Arch Intern Med
, vol.150
, pp. 1377-1378
-
-
Feinstein, A.R.1
-
43
-
-
25144446775
-
Strategies to enhance patient adherence: Making it simple
-
Atreja A, Bellam N, Levy SR. Strategies to enhance patient adherence: making it simple. MedGenMed 2005; 7: 4
-
(2005)
MedGenMed
, vol.7
, pp. 4
-
-
Atreja, A.1
Bellam, N.2
Levy, S.R.3
-
44
-
-
20444362063
-
Improving adherence to treatment for hypertension
-
Domino FJ. Improving adherence to treatment for hypertension. Am Fam Physician 2005; 71: 2089-2090
-
(2005)
Am Fam Physician
, vol.71
, pp. 2089-2090
-
-
Domino, F.J.1
-
45
-
-
0036719562
-
Patient adherence and medical treatment outcomes: A meta-analysis
-
DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes: a meta-analysis.Med Care 2002; 40: 794-811
-
(2002)
Med Care
, vol.40
, pp. 794-811
-
-
Di Matteo, M.R.1
Giordani, P.J.2
Lepper, H.S.3
-
46
-
-
65949122472
-
A review of studies of adherence with antihypertensive drugs using prescription databases
-
Fitz-Simon N, Bennett K, Feely J. A review of studies of adherence with antihypertensive drugs using prescription databases. Ther Clin Risk Manag 2005; 1: 93-106
-
(2005)
Ther Clin Risk Manag
, vol.1
, pp. 93-106
-
-
Fitz-Simon, N.1
Bennett, K.2
Feely, J.3
-
47
-
-
0030806211
-
The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: Results from a population-based study in the elderly
-
Monane M, Bohn RL, Gurwitz JH, et al. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 1997; 10: 697-704
-
(1997)
Am J Hypertens
, vol.10
, pp. 697-704
-
-
Monane, M.1
Bohn, R.L.2
Gurwitz, J.H.3
-
48
-
-
1542440031
-
Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy
-
Taylor AA, Shoheiber O. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy. Congest Heart Fail 2003; 9: 324-332
-
(2003)
Congest Heart Fail
, vol.9
, pp. 324-332
-
-
Taylor, A.A.1
Shoheiber, O.2
-
49
-
-
29244462820
-
Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: A retrospective cohort study in primary care
-
Mazzaglia G, Mantovani LG, Sturkenboom MC, et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens 2005; 23: 2093-2100
-
(2005)
J Hypertens
, vol.23
, pp. 2093-2100
-
-
Mazzaglia, G.1
Mantovani, L.G.2
Sturkenboom, M.C.3
-
50
-
-
28844436931
-
Rate and determinants of 10-year persistence with antihypertensive drugs
-
Van Wijk BL, Klungel OH, Heerdink ER, et al. Rate and determinants of 10-year persistence with antihypertensive drugs. J Hypertens 2005; 23: 2101-2107
-
(2005)
J Hypertens
, vol.23
, pp. 2101-2107
-
-
Van Wijk, B.L.1
Klungel, O.H.2
Heerdink, E.R.3
-
51
-
-
44349111871
-
Adherence to prescribed antihypertensive drug treatments: Longitudinal study of electronically compiled dosing histories
-
Vrijens B, Vincze G, Kristanto P, et al. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008; 336: 1114-1117
-
(2008)
Bmj
, vol.336
, pp. 1114-1117
-
-
Vrijens, B.1
Vincze, G.2
Kristanto, P.3
-
52
-
-
0031659477
-
Continuation of initial antihypertensive medication after 1 year of therapy
-
Bloom BS. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther 1998; 20: 671-681
-
(1998)
Clin Ther
, vol.20
, pp. 671-681
-
-
Bloom, B.S.1
-
53
-
-
0033547740
-
Persistence with treatment for hypertension in actual practice
-
Caro JJ, Salas M, Speckman JL, et al. Persistence with treatment for hypertension in actual practice. CMAJ 1999; 160: 31-37
-
(1999)
Cmaj
, vol.160
, pp. 31-37
-
-
Caro, J.J.1
Salas, M.2
Speckman, J.L.3
-
54
-
-
0031427407
-
Variations in compliance among hypertensive patients by drug class: Implications for health care costs
-
discussion 1424-1445
-
Rizzo JA, Simons WR. Variations in compliance among hypertensive patients by drug class: implications for health care costs. Clin Ther 1997; 19: 1446-1457; discussion 1424-1445
-
(1997)
Clin Ther
, vol.19
, pp. 1446-1457
-
-
Rizzo, J.A.1
Simons, W.R.2
-
55
-
-
84891561464
-
Excess dietary sodium and inadequate potassium intake by hypertensive patients in Italy: Results of the minisal-siia study program
-
Galletti F, Agabiti-Rosei E, Bernini G, et al. Excess dietary sodium and inadequate potassium intake by hypertensive patients in Italy: results of the MINISAL-SIIA study program. J Hypertens 2014; 32: 48-56
-
(2014)
J Hypertens
, vol.32
, pp. 48-56
-
-
Galletti, F.1
Agabiti-Rosei, E.2
Bernini, G.3
-
56
-
-
31544432032
-
Global approach to cardiovascular risk in chronic kidney disease: Reality and opportunities for intervention
-
De Nicola L, Minutolo R, Chiodini P, et al. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int 2006; 69: 538-545
-
(2006)
Kidney Int
, vol.69
, pp. 538-545
-
-
De Nicola, L.1
Minutolo, R.2
Chiodini, P.3
-
57
-
-
70350246278
-
Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients
-
Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009; 120: 1598-1605
-
(2009)
Circulation
, vol.120
, pp. 1598-1605
-
-
Mazzaglia, G.1
Ambrosioni, E.2
Alacqua, M.3
-
58
-
-
84885965367
-
Adherence to cardiovascular therapy: A meta-analysis of prevalence and clinical consequences
-
Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J 2013; 34: 2940-2948
-
(2013)
Eur Heart J
, vol.34
, pp. 2940-2948
-
-
Chowdhury, R.1
Khan, H.2
Heydon, E.3
-
59
-
-
49249106417
-
Resistant hypertension: Diagnosis, evaluation, and treatment a scientific statement from the American Heart Association professional education committee of the council for high blood pressure research
-
Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51: 1403-1419
-
(2008)
Hypertension
, vol.51
, pp. 1403-1419
-
-
Calhoun, D.A.1
Jones, D.2
Textor, S.3
-
60
-
-
84898731305
-
A controlled trial of renal denervation for resistant hypertension
-
Bhatt DL, Kandzari DE, O'Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370: 1393-1401
-
(2014)
N Engl J Med
, vol.370
, pp. 1393-1401
-
-
Bhatt, D.L.1
Kandzari, D.E.2
O'Neill, W.W.3
-
61
-
-
85127326105
-
Treatment adherence in hypertension: Problems and research
-
van Veen WA. Treatment adherence in hypertension: problems and research. J R Coll Gen Pract Occas Pap 1980; 12: 22-25
-
(1980)
J R Coll Gen Pract Occas Pap
, vol.12
, pp. 22-25
-
-
Van Veen, W.A.1
-
62
-
-
84877951150
-
Medication nonadherence: A diagnosable and treatable medical condition
-
Marcum ZA, Sevick MA, Handler SM. Medication nonadherence: a diagnosable and treatable medical condition. JAMA 2013; 309: 2105-2106
-
(2013)
Jama
, vol.309
, pp. 2105-2106
-
-
Marcum, Z.A.1
Sevick, M.A.2
Handler, S.M.3
-
63
-
-
0018747749
-
Guidelines for professionals
-
Patient behavior for blood pressure control
-
Patient behavior for blood pressure control. Guidelines for professionals. JAMA 1979; 241: 2534-2537
-
(1979)
Jama
, vol.241
, pp. 2534-2537
-
-
-
64
-
-
48249105871
-
Integration of depression and hypertension treatment: A pilot, randomized controlled trial
-
Bogner HR, de Vries HF. Integration of depression and hypertension treatment: a pilot, randomized controlled trial. Ann Fam Med 2008; 6: 295-301
-
(2008)
Ann Fam Med
, vol.6
, pp. 295-301
-
-
Bogner, H.R.1
De Vries, H.F.2
-
65
-
-
15944394816
-
Nurse administered telephone intervention for blood pressure control: A patient-tailored multifactorial intervention
-
Bosworth HB, Olsen MK, Gentry P, et al. Nurse administered telephone intervention for blood pressure control: a patient-tailored multifactorial intervention. Patient Educ Couns 2005; 57: 5-14
-
(2005)
Patient Educ Couns
, vol.57
, pp. 5-14
-
-
Bosworth, H.B.1
Olsen, M.K.2
Gentry, P.3
-
66
-
-
39149103069
-
Take control of your blood pressure (tcyb) study: A multifactorial tailored behavioral and educational intervention for achieving blood pressure control
-
Bosworth HB, Olsen MK, Neary A, et al. Take Control of Your Blood Pressure (TCYB) study: a multifactorial tailored behavioral and educational intervention for achieving blood pressure control. Patient Educ Couns 2008; 70: 338-347
-
(2008)
Patient Educ Couns
, vol.70
, pp. 338-347
-
-
Bosworth, H.B.1
Olsen, M.K.2
Neary, A.3
-
67
-
-
73249153446
-
Physician and pharmacist collaboration to improve blood pressure control
-
Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med 2009; 169: 1996-2002
-
(2009)
Arch Intern Med
, vol.169
, pp. 1996-2002
-
-
Carter, B.L.1
Ardery, G.2
Dawson, J.D.3
-
68
-
-
0029871819
-
A telecommunications system for monitoring and counseling patients with hypertension impact on medication adherence and blood pressure control
-
Friedman RH, Kazis LE, Jette A, et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens 1996; 9: 285-292
-
(1996)
Am J Hypertens
, vol.9
, pp. 285-292
-
-
Friedman, R.H.1
Kazis, L.E.2
Jette, A.3
-
69
-
-
33846316038
-
Efficacy of a transtheoretical model-based expert system for antihypertensive adherence
-
Johnson SS, Driskell MM, Johnson JL, et al. Efficacy of a transtheoretical model-based expert system for antihypertensive adherence. Dis Manag 2006; 9: 291-301
-
(2006)
Dis Manag
, vol.9
, pp. 291-301
-
-
Johnson, S.S.1
Driskell, M.M.2
Johnson, J.L.3
-
70
-
-
5444264398
-
Nurse management for hypertension. A systems approach
-
Rudd P, Miller NH, Kaufman J, et al. Nurse management for hypertension. A systems approach. Am J Hypertens 2004; 17: 921-927
-
(2004)
Am J Hypertens
, vol.17
, pp. 921-927
-
-
Rudd, P.1
Miller, N.H.2
Kaufman, J.3
-
71
-
-
79957610344
-
Effectiveness of home telehealth in comorbid diabetes and hypertension: A randomized, controlled trial
-
Wakefield BJ, Holman JE, Ray A, et al. Effectiveness of home telehealth in comorbid diabetes and hypertension: a randomized, controlled trial. Telemed J E Health 2011; 17: 254-261
-
(2011)
Telemed J e Health
, vol.17
, pp. 254-261
-
-
Wakefield, B.J.1
Holman, J.E.2
Ray, A.3
-
72
-
-
0032162003
-
Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study
-
Solomon DK, Portner TS, Bass GE, et al. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc (Wash) 1998; 38: 574-585
-
(1998)
J Am Pharm Assoc (Wash
, vol.38
, pp. 574-585
-
-
Solomon, D.K.1
Portner, T.S.2
Bass, G.E.3
-
73
-
-
0036894205
-
Improving blood pressure control in a pharmacist-managed hypertension clinic
-
Vivian EM. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy 2002; 22: 1533-1540
-
(2002)
Pharmacotherapy
, vol.22
, pp. 1533-1540
-
-
Vivian, E.M.1
-
74
-
-
33845450660
-
Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: A randomized controlled trial
-
Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 2006; 296: 2563-2571
-
(2006)
Jama
, vol.296
, pp. 2563-2571
-
-
Lee, J.K.1
Grace, K.A.2
Taylor, A.J.3
-
75
-
-
32644445066
-
Effects of enhanced depression treatment on diabetes self-care
-
Lin EH, Katon W, Rutter C, et al. Effects of enhanced depression treatment on diabetes self-care. Ann Fam Med 2006; 4: 46-53
-
(2006)
Ann Fam Med
, vol.4
, pp. 46-53
-
-
Lin, E.H.1
Katon, W.2
Rutter, C.3
-
76
-
-
47749150662
-
Cardiovascular risk education and social support (caress): Report of a randomized controlled trial from the Kentucky ambulatory network (kan
-
Pearce KA, Love MM, Shelton BJ, et al. Cardiovascular risk education and social support (CaRESS): report of a randomized controlled trial from the Kentucky Ambulatory Network (KAN) J Am Board Fam Med 2008; 21: 269-281
-
(2008)
J Am Board Fam Med
, vol.21
, pp. 269-281
-
-
Pearce, K.A.1
Love, M.M.2
Shelton, B.J.3
-
77
-
-
0028884120
-
Failure of educational videotapes to improve medication compliance in a health maintenance organization
-
Powell KM, Edgren B. Failure of educational videotapes to improve medication compliance in a health maintenance organization. Am J Health Syst Pharm 1995; 52: 2196-2199
-
(1995)
Am J Health Syst Pharm
, vol.52
, pp. 2196-2199
-
-
Powell, K.M.1
Edgren, B.2
-
78
-
-
38749110090
-
Impact of medication packaging on adherence and treatment outcomes in older ambulatory patients
-
Schneider PJ, Murphy JE, Pedersen CA. Impact of medication packaging on adherence and treatment outcomes in older ambulatory patients. J Am Pharm Assoc (2003) 2008; 48: 58-63
-
(2008)
J Am Pharm Assoc. 2003
, vol.48
, pp. 58-63
-
-
Schneider, P.J.1
Murphy, J.E.2
Pedersen, C.A.3
-
79
-
-
57249094301
-
A randomized controlled trial of team-based care: Impact of physician-pharmacist collaboration on uncontrolled hypertension
-
Hunt JS, Siemienczuk J, Pape G, et al. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med 2008; 23: 1966-1972
-
(2008)
J Gen Intern Med
, vol.23
, pp. 1966-1972
-
-
Hunt, J.S.1
Siemienczuk, J.2
Pape, G.3
-
80
-
-
84897019266
-
Closing the quality gap: Revisiting the state of the science 4: Medication adherence interventions: Comparative effectiveness
-
Viswanathan M, Golin CE, Jones CD, et al. Closing the quality gap: revisiting the state of the science (vol. 4: medication adherence interventions: comparative effectiveness) Evid Rep Technol Assess (Full Rep) 2012; 4: 1-685
-
(2012)
Evid Rep Technol Assess (Full Rep
, vol.4
, pp. 1-685
-
-
Viswanathan, M.1
Golin, C.E.2
Jones, C.D.3
-
81
-
-
77952295236
-
Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications
-
Maciejewski ML, Bryson CL, Perkins M, et al. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications. Am J Manag Care 2010; 16: e20-e34
-
(2010)
Am J Manag Care
, vol.16
, pp. e20-e34
-
-
Maciejewski, M.L.1
Bryson, C.L.2
Perkins, M.3
-
82
-
-
77951620905
-
The impact of medicare part d on medication adherence among older adults enrolled in medicare-advantage products
-
Zhang Y, Lave JR, Donohue JM, et al. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Med Care 2010; 48: 409-417
-
(2010)
Med Care
, vol.48
, pp. 409-417
-
-
Zhang, Y.1
Lave, J.R.2
Donohue, J.M.3
|